Laughing gas shows promise for stubborn depression in new trial

NCT ID NCT07262008

First seen Jan 04, 2026 · Last updated May 15, 2026 · Updated 20 times

Summary

This study tests whether nitrous oxide, commonly known as laughing gas, can reduce symptoms of depression in people whose depression has not improved with standard treatments. About 120 adults aged 18 to 65 with treatment-resistant depression will receive either the gas or a placebo in a blinded setup. The main goal is to see if depression scores improve over 12 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • St. Michael's Hospital (Unity Health)

    Toronto, Ontario, M5B 1W8, Canada

  • Sunnybrook Health Sciences Centre

    Toronto, Ontario, M4N 3M5, Canada

  • Toronto General Hospital (UHN)

    Toronto, Ontario, M5G 2C4, Canada

  • Toronto Western Hospital (UHN)

    Toronto, Ontario, M5T 2S8, Canada

  • Women's College Hospital

    Toronto, Ontario, M5S 1B2, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.